HealthRX.com · Printable symptom log
Wegovy after weight-loss surgery: low-sugar episodes, dose steps and fluids record
Start with the surgery history the prescriber needs, then log any shaky, sweaty or confused spell after meals and how each dose step goes for nausea and fluids. The label points on low blood sugar and fluid loss are printed on the sheet.
Surgery and weight history
Procedure and dategastric bypass, sleeve, band, revision
Lowest weight after surgery, and when
Weight now, and how much has come back
Shaky, sweaty or confused spells 1 to 3 hours after eating?
Diabetes medicinesinsulin or a sulfonylurea raise the risk of low blood sugar
Bariatric team or endocrinologist contact
Possible low-sugar episodes
| Date and time | Time since last meal | What you ate | Symptoms | Glucose reading, if checked | What you did | Wegovy dose |
|---|---|---|---|---|---|---|
Each dose step
| Week | Dose | Days with nausea or vomiting | Full after a few bites? | Kept fluids down? | Weight |
|---|---|---|---|---|---|
What the label and the clinic records say
- The label names a history of bariatric surgery as a risk factor for hypoglycemia: serious episodes in 2.3% (2 of 87) on Wegovy injection and 0% (0 of 97) on placebo.[1]
- Semaglutide from Wegovy tablets is absorbed mainly in the stomach.[1]
- If a dose step is not tolerated, the label says consider delaying escalation for 4 weeks.[1]
- In one clinic's records, weight fell 10.3% by 6 months on semaglutide of no more than 0.5 mg a week.[2]
- The same group's follow-up report gives 14.7% at 12 months; its abstract does not state the semaglutide dose.[3]
Act on these
- Dizziness, sweating, shakiness, blurred vision, slurred speech, weakness, confusion or drowsiness, or a fast heartbeat can be low blood sugar: ask your healthcare provider in advance how to recognize and treat it.[1]
- Severe stomach pain that will not go away, with or without nausea or vomiting: stop Wegovy and call your healthcare provider right away.[1]
- Nausea, vomiting or diarrhea that does not go away: tell your healthcare provider right away.[1]
Sources for the facts on this sheet
- Novo Nordisk, via DailyMed. Wegovy (semaglutide) injection, for subcutaneous use, and Wegovy (semaglutide) tablets, for oral use: prescribing information and Medication Guide. Effective 2026-06-18. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- Lautenbach A, Wernecke M, Huber TB, et al. The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery-a Retrospective Analysis. Obes Surg 2022. PMID 35879524. https://pubmed.ncbi.nlm.nih.gov/35879524/
- Lautenbach A, Kantowski T, Wagner J, et al. Sustained weight loss with semaglutide once weekly in patients without type 2 diabetes and post-bariatric treatment failure. Clin Obes 2023. PMID 37364260. https://pubmed.ncbi.nlm.nih.gov/37364260/
This sheet records information for a conversation with your prescriber or pharmacist. It does not replace their instructions or the medication's prescribing information.